Does something feel off?

The people, processes, and skills that built the business are rarely the same ones required to exit.

The company you run every day may not translate cleanly to how buyers, investors, or partners see it from the outside.

Schedule an Exit Readiness Diagnostic to find out ->

Strong revenue performance doesn’t always equal strong valuation when you’re looking to transfer ownership.

When strong businesses prepare for an exit, valuation risk often lies in how the story transfers.

Valuations can appear to be problems that you can diagnose on a spreadsheet.

In reality, they surface in conversations: the stories you tell your clients, employees, partners, board, and buyers.
As you know, value is ultimately defined by what someone’s willing to pay.
Buyers simplify what you do and miss what actually makes the business durable.
Strong metrics still prompt cautious questions rather than confidence.
Brand, GTM, and investor narratives appear related but aren’t aligned.
Sales cycles and partnerships drag because the story is shifting.
Exit discussions expose gaps in growth strategies when it’s too late.
None of this means the company is weaker than you think.
It means the market doesn’t fully understand what it’s buying.

The presentation to buyers is radically different than the founder’s story you’ve been telling for years.

How Legacy DNA helps founders maximize their exit

Based on the stage you’re actually in...
Not every founder needs the same intervention.
Timing matters.
If you’re seeking clarity before scale or exit…
The Exit Readiness Sprint provides structure for how your company presents itself. It aligns your story, positioning, and proof so customers and buyers understand the value faster and with less friction.
If you’ve already gone to market and met buyers with interest but not urgency…
The Premium Acquisition Sprint sharpens your narrative, evidence, and differentiation so acquirers see you as a category leader, not a comparable.
If growth must compound into valuation as you scale before exit…
The Growth Engine Partnership builds a sustained commercialization system that ties demand, revenue, and credibility directly to enterprise value.
Each path is designed to address a specific risk, leverage your available time to exit, and maximize your legacy.
Book my Exit Readiness Diagnostic consultation
WHAT OUR CLIENTS SAY
“Before the Exit Readiness Sprint, I didn't have an appreciation for what a successful external engagement could bring to the business. The work that Legacy DNA has done over the last 3 months will drive more value than I was ever expecting going into the engagement. I will make the decision to use Legacy DNA time and time again regardless of where my career takes me.”
— Natasha Hennessy, CEO of Apotheco Medicinals

The Legacy DNA philosophy

Undervaluation is usually a perception problem before it becomes a performance problem. Buyers form opinions long before diligence begins, and those opinions are hard to outrun under time pressure.

A clear, credible commercial story is an asset. It reduces friction, shortens cycles, and protects value. Speed matters because exits operate on fixed timelines, even when businesses don’t.

Our framework changes outcomes

Legacy DNA has helped healthtech and pharmacy companies:

  • Scale from mid-market growth to multi-billion-dollar outcomes
  • Move from stalled conversations to premium acquisition interest
  • Enter exit processes with clearer positioning and fewer late-stage surprises

We consistently focus on valuation drivers, not surface metrics. We’ve guided four successful exits. Our executives have doctorate-level strategic rigor paired with operator experience, and we leverage a deep understanding of commercialization, regulatory complexity, and buyer psychology.

We've helped leadership teams navigate four Successful exits by turning strong businesses into stories buyers recognize, trust, and value.

Your next step on your terms

Start with the Exit Readiness Scorecard

This is a private, 10-question diagnostic survey that clarifies how your company currently presents to buyers and identifies potential risks. No benchmarking. No judgment. Just insight into your readiness.

Get my Exit Readiness Scorecard

Jump ahead to a Diagnostic Conversation

We offer a strategic discussion with one of our senior executives. We’ll interpret the scorecard's findings or your own analysis of the situation and determine if it’s time to take action.

Book my Exit Readiness Diagnostic consultation